WPWahyu Aristyaning Putri

Wahyu Aristyaning Putri

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Wahyu Aristyaning Putri has a total of 110 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Orange-pigmented Paracoccus marcusii, symbiotic with the coral Favites sp., shows antibacterial properties against multidrug-resistant (MDR) clinical samples

    by Muhammad Evy Prastiyanto, Afifah Khairunnisa, Muhammad Hizbul Wathon, Lia Kusmita, Aninditia Sabdaningsih, Rizal Maarif Rukmana, Wahyu Aristyaning Putri

    1. The increasing prevalence of multidrug-resistant (MDR) bacteria poses a significant threat to public health (Prastiyanto et al. 2024), necessitating the urgent development of novel antibacterial...

  • Open Access

    Targeting urinary tract infections: Anti-MDR efficacy of Syzygium aromaticum small molecules against uropathogenic Escherichia coli through in vitro and in silico approaches

    by Farhan Kesawa Mukti, Fairuz Fajriani Kusumaningrum, Muhammad Evy Prastiyanto, Daniel Geleta, Abdul Rahman Siregar, Wahyu Aristyaning Putri

    Urinary tract infections (UTIs) are becoming increasingly challenging to treat owing to the emergence of multidrug-resistant (MDR) strains, including uropathogenic Escherichia coli (UPEC). Clove (Syzygium aromaticum L.) has antimicrobial activity that can alter UPEC morphology and exhibit inhibitory effects. However, the mechanisms underlying the inhibition of specific small molecules remain largely unknown. This study aimed to explore the potential of small molecules in clove flower extract as anti-MDR UPEC agents using in vitro and in silico approaches. Extraction was performed using ethanol and n-hexane, yielding 27.44% and 9.9%, respectively. The ethanol extract exhibited inhibitory activity against MDR-UPEC, forming clear zones ranging from 11.07±0.32 (250 mg/mL) to 16.77±1.36 (1,000 mg/mL) in a disk diffusion assay. However, the combination of ethanol extract and ciprofloxacin resulted in antagonistic effects. GC-MS analysis of the ethanol extract identified 29 small molecules, which were subsequently analyzed using PASS Online, Lipinski’s Rule of Five, and molecular docking against target proteins PBP2 and AcrB. Three small molecules showed the potential to inhibit PBP2, and ten small molecules targeted AcrB. Spesifically, 8,14-Seco-3,19-epoxyandrostane-8,14-dione, 17-acetoxy-3β-methoxy-4,4-dimethyl-, Ethyl iso-allocholate and Estra-1,3,5(10)-trien-17β-ol show binding affinities of –7.9; –7.6; dan –8.0 kcal/mol to PBP2, and –9.3; –8.5; dan –8.6 kcal/mol to AcrB, respectively. These three small molecules are promising candidates for developing plant-based antibacterial agents against MDR UPEC.


  • Open Access

    An integrative multi-omics approach to decipher the polypharmacological mechanism of okra (Abelmoschus esculentus) against type 2 diabetes mellitus

    by W. A. S. Tunjung, D. H. Utomo, A. B. Patricia, A. N. Arfa, C. Z. Kurniawan, A. Maharani, L. Nurhidayat, W. A. Putri, I. Rosyadi, W. D. Saputra, et al.

    Type 2 diabetes mellitus (T2DM) is a complex polygenic metabolic disorder involving dysregulation of multiple genes and signaling pathways. Okra (Abelmoschus esculentus) has shown antidiabetic potential, although its molecular mechanisms remain inadequately understood. This study investigated the antidiabetic properties of okra using an integrative in silico approach. A total of 108 bioactive compounds were identified, with flavonoids as the predominant group. Transcriptomic analysis of the GSE21321 dataset identified 17 significantly dysregulated genes (DEGs) in T2DM patients. Gene Ontology and KEGG enrichment analyses revealed significant involvement in insulin signaling, PI3K/AKT, FoxO, and apoptosis-related pathways, highlighting the polygenic nature of T2DM. Compound-target interaction and network analyses identified key interactions between okra bioactives and diabetes-related proteins, including PTPN11, BCL2L1, INSR, and IGF1R. Molecular docking revealed predicted binding affinities, with quercetin showing the strongest interaction with IGF1R (-7.3 kcal/mol), suggesting its potential role in insulin signaling modulation. Organic acids, such as fumarate, malate, and citric acid, act as supportive modulators. ADME and toxicity predictions indicated favorable drug-likeness and generally low toxicity profiles. Overall, this study suggests that okra exerts antidiabetic effects through multi-target modulation of key molecular pathways, supporting its potential as a natural therapeutic candidate for T2DM management.


  • Open Access

    Transcriptomic Insights Into the Evolution of Snake Venom: Mechanisms, Diversity, and Adaptation

    by Fajar Sofyantoro, Wisnu Ananta Kusuma, Setyanto Tri Wahyudi, Favorisen Rosyking Lumbanraja, Hendra Rahmawan, Heru Cahya Rustamaji, Dhadhang Wahyu Kurniawan, Undri Rastuti, Wahyu Aristyaning Putri, Wiko Arif Wibowo, et al.

    Snake venoms are evolutionarily refined biochemical arsenals composed of diverse toxins with complex functional roles in predation, defense, and competition. Over the past 2 decades, transcriptomic approaches have transformed venom research by enabling high‐resolution insights into gene expression dynamics, molecular diversity, and the evolutionary mechanisms driving venom variation across lineages. In this review, we present a comprehensive synthesis of snake venom transcriptomics literature and propose a conceptual framework structured around three major axes: (1) gene family expansion through duplication and neofunctionalization; (2) regulatory complexity encompassing transcriptional, posttranscriptional, and epigenetic modulation; and (3) ecological selection pressures shaping venom profiles in response to diet, habitat, and interspecific interactions. We integrate findings from diverse taxa and technologies, including bulk RNA sequencing, long‐read transcriptomics, and spatial or single‐cell approaches, to highlight progress and gaps in current knowledge. A bibliometric analysis of 358 studies from 2002 to 2024 reveals significant growth in the field, with key contributions from institutions in the United States, Brazil, and Australia. Despite this progress, transcriptomic research remains geographically and taxonomically biased, with challenges in toxin annotation, data standardization, and integrative multiomics still unresolved. We conclude by emphasizing the growing role of integration with other omics approaches, advancements in single‐cell transcriptomics, and the emerging potential of computational modeling in reconstructing venom evolution.


  • Open Access

    Anticancer activity of eugenol from clove (Syzygium aromaticum L.) against MCF-7 breast cancer cells: In silico and in vitro evaluation

    by Siti Hajar Permatahati Shofyani, Muhammad Evy Prastiyanto, Daniel Geleta, Wahyu Aristyaning Putri

    Breast cancer is a major cause of cancer-related deaths among women globally. Despite notable progress in the treatment options, the pursuit of effective natural-based therapeutic alternatives continues to be essential. Syzygium aromaticum L. (cloves) is rich in eugenol, a phenolic compound known for its antimicrobial, anti-inflammatory, and anticancer effects. This study aimed to assess the anticancer activity of eugenol extracted from cloves against MCF-7 breast cancer cells using in silico molecular docking and in vitro cytotoxicity assays. The cloves collected from Natuna District and Magetan District (Indonesia) were extracted through Soxhlet extraction with n-hexane and maceration with ethanol. Gas Chromatography-Mass Spectrometry (GC-MS) analysis identified eugenol as the primary component, making up 53.6% of the Soxhlet extract. The molecular docking results indicated that eugenol has significant binding affinities for AKT (-5.1kcal/mol) and ESR1 (-5.9kcal/mol), two essential proteins involved in the proliferation and survival of breast cancer cells. Cytotoxicity assessments using the MTT assay revealed a dose-dependent decrease in MCF-7 cell viability, with notable inhibition occurring at concentrations between 15.625 and 2.000ppm. These results suggest that the eugenol-rich clove extract demonstrates promising anticancer potential by exerting direct cytotoxic effects and influencing key molecular targets within the breast cancer signalling pathway.

  • Open Access

    Valorization of Shrimp Shell Waste: Comparative Phytochemical Composition and Bioactivity of Parapenaeus longirostris and Aristeus antennatus

    by Essaid Zeghdoudi, Ahmed Nouar, Mohammed Cheurfa, Chaimaa Noun, Imane Kouider Mohammadi, Wahyu Aristyaning Putri, Valentina Fernandes Domingues

    The valorization of marine by-products represents a promising approach for discovering novel bioactive compounds. This study presents a comparative phytochemical and bioactivity assessment of shrimp shell waste extracts from Parapenaeus longirostris and Aristeus antennatus species, which are prevalent on Algerian coasts. The objective of this study is to evaluate their potential as a source of biologically active compounds, with a particular focus on those compounds that possess anti-inflammatory and antidiabetic properties. The methodology entailed the extraction of chemical compounds. The subsequent procedure involved the utilization of shrimp residues, which were then subjected to a comprehensive compositional analysis. This analysis was then followed by an evaluation of their biological activity. The results obtained demonstrated the presence of biologically effective compounds, with the extracts exhibiting notable anti-inflammatory and antidiabetic activity. White shrimp (P. longirostris) was found to be particularly efficacious in both activities, showing particular promise in diabetes-related inhibition. This finding indicates the potential of valorization. It is evident that these marine by-products have the potential to serve as a promising natural resource for the development of value-added products. It is evident that these initiatives facilitate novel advancements in the domains of health and industry, thus underpinning the blue economy within the paradigm of sustainable development.


  • Open Access

    Emergence of multidrug resistance in urinary tract infections patients worldwide (1976–2024): Bibliometric analysis

    by Wahyu Aristyaning Putri, Jajar Setiawan, Muhammad Evy Prastiyanto, Fajar Sofyantoro, Abdul Rahman Siregar, Anjar Tri Wibowo


  • Open Access

    Global Perspectives on Environmental Microbiome Research: Current Status and Future Directions

    by Wahyu Aristyaning Putri, Aprilia Sufi Subiastuti, Cahyo Wulandari, Mifta Pratiwi Rachman, Alfino Sebastian, Abdul Rahman Siregar, Tyas Ikhsan Himawan, Dwi Sendi Priyono, Neng Tanty Sofyana, Yekti Asih Purwestri, et al.

    The environmental microbiome plays an important role in various ecosystems around the world, influencing nutrient cycling, disease dynamics and ecosystem stability. This bibliometric analysis provides a comprehensive overview of the current state and future directions of environmental microbiome research from a global perspective from 2009–2024. Through systematic examination of Scopus publications, 2154 documents were found. The results show a significant increase in the number of publications since 2017 and a peak in 2024. The most cited document was "The hidden world within plants: Ecological and evolutionary considerations for defining functioning of microbial endophytes" with 1887 citations and “Structure and function of the global ocean microbiome” with 1843 citations. The most productive countries in environmental microbiome research are the United States (n = 748), China (n = 533), India (n = 308), Germany (n = 172) and the United Kingdom (n = 157). Microbiome, microbial community, microfolora, microbiota, microbiology, bacteria, and bacterium are the most popular topics that will continue to develop in the future. Although the United States has published the highest total number of papers, more recent studies have predominantly been published from China, indicating shift in the centre of study from the United States to China. Insights gained from this analysis contribute to a deeper understanding of the environmental microbiome research landscape, guiding future research priorities and collaborations in the field.

  • Open Access

    Birds-of-paradise (Paradisaeidae) research: analysing research trends from 1862 to 2023

    by Hapiz Al Khairi, Budi Setiadi Daryono, Dwi Sendi Priyono, Fajar Sofyantoro, Wahyu Aristyaning Putri, Nur Indah Septriani

    The Birds-of-Paradise (BoPs), celebrated for their exquisite plumage and significant historical allure, have faced threats from deforestation and hunting, necessitating ongoing conservation efforts. This study employs bibliometric analysis to examine the scientific literature on BoPs from 1862 to 2023, focusing on publication trends, influential countries, institutions, authors, and funding sources. By employing the Scopus database and VOSviewer for data visualisation, we have successfully identified a total of 255 publications, which include articles, reviews, and a variety of document types. Overall, the species of the genus Paradisaea are the most discussed. From a total of 44 species, only one species of BoPs is highlighted among all the papers examined using VOSviewer: Lophorina superba (n=14). This suggests that many other BoPs species have not received sufficient research attention. The analysis reveals a gradual increase in research interest since the 1970s, with the United States, Australia, and the United Kingdom leading in publication output. The study also maps the evolution of research topics, showing shifts from biogeography and species classification to phylogenetics and sexual selection. This comprehensive overview underscores the global research efforts and evolving focus areas, aiming to enhance awareness and guide future studies in BoPs conservation.

  • Anti-multidrug resistance: A narrative review

    by Wahyu Aristyaning Putri, Abdul Rahman Siregar, Fajar Sofyantoro, Shihiko Yano, Muhammad Evy Prastiyanto, Anjar Tri Wibowo

    Background: The escalating challenge of antimicrobial resistance and multidrug-resistant organisms represents a profound threat to global health systems, underscoring an urgent need for transformative therapeutic strategies. This overview examines current pharmacological solutions and emerging compounds with anti-multidrug-resistant potential. While traditional antimicrobials falter, novel interventions sourced from diverse biological origins; small molecules derived from plants, microbial by products, and fungal metabolites offer promising alternative pathways. Active peptides and structurally unique novel antibiotics represent another frontier in dismantling resistance mechanisms. Furthermore, compounds beyond conventional antimicrobials exhibit auxiliary roles that potentiate existing treatments or directly inhibit resistance pathways. Advances in technology also hold potential to address antimicrobial resistance through highly specific and efficient solutions. Genome editing tools enable precise modifications to pathogen genomes, while nanotechnology facilitates targeted drug delivery, minimizing off-target effects. Artificial intelligence and machine learning algorithms further enhance our ability to predict resistance patterns and optimize drug discovery pipelines, accelerating the development of next-generation antimicrobials. Collectively, these multidisciplinary innovations foster a novel therapeutic landscape, offering hope for a future where the threat of multidrug-resistant pathogens can be effectively managed and mitigated.